Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: Neuromyelitis Optica Spectrum Disorders

Sustained long-term efficacy and safety of satralizumab in NMOSD

Presented By
Prof. Jeffrey Bennett, University of Colorado Hospital, CO, USA
Trial
Phase 3, SAkuraSky; SAkuraStar
Conference
AAN 2022

2 June, 2022 15:29

Serum glial fibrillary acidic protein predicts relapses in NMOSD

Conference
MS Virtual 2020

25 November, 2020 17:06

Gut dysbiosis in NMOSD promotes CNS autoimmunity

Conference
MS Virtual 2020

25 November, 2020 16:46

NG-specific biomarkers differentiate NMOSD from MS

Conference
MS Virtual 2020

25 November, 2020 16:46

Eculizumab reduces long-term relapse risk in AQP4-positive NMOSD

Trial
Phase 3, PREVENT
Conference
MS Virtual 2020

25 November, 2020 16:45

Satralizumab lowers risk of severe relapse in NMOSD patients

Trial
SAkuraSky, SAkuraStar
Conference
MS Virtual 2020

25 November, 2020 16:45

Genetic association studies in NMOSD needed

Presented By
Dr Viktoria Papp, Aarhus University Hospital, Denmark
Conference
EAN 2020

10 September, 2020 14:08

Eculizumab in NMOSD: the PREVENT study

Presented By
Dr Celia Oreja-Guevara, Hospital Clínico San Carlos, Spain
Trial
Phase 3, PREVENT
Conference
EAN 2020

10 September, 2020 14:03

Long-term safety of satralizumab consistent with double-blind periods

Presented By
Prof. Benjamin Greenberg, University of Texas Southwestern Medical Center, USA
Trial
Phase 3, SAkuraSky; SAkuraStar
Conference
EAN 2020

10 September, 2020 13:58

Risk of hypogammaglobulinemia and rituximab

Presented By
Dr Susanna Hallberg, Karolinska Institute, Sweden
Conference
ECTRIMS 2019

8 November, 2019 21:18

Late-breaking: Role for CSF markers in autoimmune astrocytopathies

Presented By
Dr Iris Kleerekooper, University College London, United Kingdom
Conference
ECTRIMS 2019

8 November, 2019 20:13

Targeted therapies for NMOSD in development

Presented By
Dr Dean Wingerchuk, Mayo Clinic, Rochester, United States
Trial
Phase 3, PREVENT
Conference
ECTRIMS 2019

8 November, 2019 11:17

Promising results of novel NMOSD treatments

Conference
EAN 2019

27 August, 2019 09:40

Three very promising new treatments of NMOSD

Presented By
Dr Stacey Clardy & Prof. Bruce Cree
Trial
PREVENT, SAkuraSky
Conference
AAN 2019

30 July, 2019 23:07

Immune tolerance by peptide-loaded tolerogenic dendritic cells

Expert
Dr Irati Zubizarreta, Institut d’Investigacions Biomediques August Pi Sunyer, Spain
Conference
AAN 2019

30 July, 2019 22:08
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy